Genome Advisory proudly creates and co-hosts bespoke events with celebrated biologic and social scientists, physicians, ethicists, legal experts and wealth advisors.



Institute for-private-investors-ipi-spring-forum

Dr. Ronnie Stangler spoke at the Institute for Private Investors | Campden Wealth Spring Forum in NYC. Her talk, "Reimagining Longevity: Epigenetic Engineering", simultaneously addressed both health span and investment portfolios.



Ronnie S. Stangler, M.D., was delighted to return to the Harvard Business School Executive Education Program for Family Offices. She assisted in the presentation of "Genomics in the Family Office", a case study she co-authored with Professor Lauren Cohen and Spencer Hagist.



Dr. Stangler presented a keynote address to the Institute for Private Investors | Campden Wealth Winter Forum in San Francisco at the Wharton Business School West Coast Campus.



Dr. Stangler was honored to deliver a keynote address, Reimagining Medicine: Epigenetic Engineering at the 29th Annual World Congress of the American Academy of Anti-Aging Medicine (A4M) in Las Vegas.



Genome Advisory had the pleasure of speaking at Prestel & Partner’s Family Office Forum at the Harvard Club in New York City. Dr. Stangler addressed the application of DNA sciences to the family office in her session “Genomics and Its Impact on Families of Wealth”.



Dr. Stangler was honored to deliver a virtual presentation, "Strategies and Tools for Optimal Performance", to a private cohort of C200 and AccessCircles members. Her presentation focused on the science of change and identified actionable practices to foster neuroplasticity and deep learning.



Dr. Stangler contributed to the teaching of "Genomics in the Family Office", a case study she co-authored with Harvard Business School Professor Lauren Cohen. The case profiles a prominent Israeli family challenged by a rare genetic disorder and addresses its impact on family dynamics, health planning, and philanthropic strategy.



Preston Estep, Ph.D., Co-Founder and Director of the Rapid Deployment Vaccine Collaborative (RaDVaC) and author of “The Mindspan Diet”, facilitated by Ronnie S. Stangler, M.D., discussed “Prevention with 2020 Foresight: Surviving and Thriving Beyond the Pandemic” at Aspen Brain Institute’s Expert Series 2.0.



Morgan Levine, Ph.D. (Faculty at Yale School of Medicine and Advisor to Elysium Health), facilitated by Ronnie S. Stangler, M.D., addressed how tracking biological age can help us optimize our health, as well as presented science aimed at literally changing the pace of our aging at Aspen Brain Institute’s Expert Series 2.0.



Robert Green, M.D., M.P.H., facilitated by Ronnie S. Stangler, M.D., addressed exciting new findings in genomics which are revolutionizing medical care across multiple disciplines, preventing illness and extending healthy lifespan at Aspen Brain Institute’s Expert Series 2.0.



Genome Advisory joined WHAM! (Women's Health Access Matters) and pgEd (Personal Genetics Education Project) in the laboratory of Dr. Ting Wu at the Department of Genetics, Harvard Medical School, to explore the powerful interplay between genomics and gender.



The Personal Genetics Education Project (pgEd) returned to Capitol Hill to hold its sixth Congressional briefing: The Common Thread: What Genetics Tells Us About Ancestry, Health and Personal Identity in cooperation with the offices of Senator Elizabeth Warren and Congressman Bill Foster.

This briefing explored how advances in genetics are producing new tools for investigating commonalities and differences across human populations, and their implications for precision medicine, racial identity and beyond.



Our ability to sequence genomes, essentially identifying all components of our DNA, combined with big data analysis and technologies that will allow us to edit DNA, have profound implications on human health and longevity. Related opportunities abound in career and professional development, investment, and philanthropy..



"The Enhanced Human: Risks and Opportunities" examined existing and emerging enhancement technologies, with a special focus on gene editing and artificial intelligence, as examples of technologies with broad capabilities and ethical concerns. Panelists provided an historical perspective, scientific background, and delved into ethical, social and behavioral questions still to be addressed.



This summit continued our exploration of the intersection between the hugely accelerating genomics revolution and its impact on families of wealth. It furthered necessary critical conversation about disruptive genomic technologies, and provided unique opportunity for global families, family offices and enterprise to dialogue in an intimate setting with the world's greatest genomic scientists.



On 12 October 2017, Drs. George Church, Ting Wu and Ronnie Stangler hosted an intimate gathering in NYC of investors, philanthropists, social entrepreneurs, family office advisors, medical consultants and public intellectuals, a core working group committed to ensuring the ethical applications of genomic science.



This summit represented the first gathering of global families, family offices and enterprise with the world's greatest genomic scientists to explore the imminent impact of profoundly disruptive genomic technologies. Ethical, social, legal and behavioral challenges facing families of wealth were highlighted, as were legacy creation and philanthropy.



The Family Firm Institute
2016 Global Conference
October 26-29, 2016

Most family enterprise today approach next generation preparation and succession planning by generic anticipation of the uncertain and hedging the unknown. Quantum advances in genomics will allow for far greater sophistication of understanding of human capital. Imminent new medical knowledge will change families’ approach to operation and succession and the way in which key advisors support informed families.

Please be in touch

Your genomics journey begins with a conversation. We look forward to hearing from you.
Please email us at or use the contact form below.

Life sciences are progressing at an exponential rate

Learn about actionable developments and insights